You searched for "therapeutics"

276 results found

Bausch+Lomb hosts inaugural international refractive meeting in Lisbon

In February, Bausch + Lomb hosted Hi-Tech days, an educational event focused on premium refractive technologies. This meeting brought together international speakers to discuss a wide range of topics in Cataract, Corneal and Refractive surgery including FLACS, Premium IOLs, Astigmatism, Refractive surgery and Therapeutics as well as discussions around interesting and challenging cases.

Update on emerging therapies for age-related macular degeneration

The 23rd European Society of Retina Specialists (EURETINA) Congress, held in Amsterdam, the Netherlands, provided a timely update on anti-complement therapy for geographic atrophy and emerging investigational therapies for neovascular age-related macular degeneration. Anti-complement therapy for geographic atrophy Geographic atrophy...

A curry a day could keep the ophthalmologist away

Simerdip Kaur takes a look at the latest ophthalmology-related news stories and asks which are based on facts and which are ‘fake news’. Headline: A curry a day could keep the ophthalmologist away The dietary supplement market is a multibillion-dollar...

What's trending Dec/Jan 2021

A round-up of the eye-related hot topics that have been trending on social media over the last few weeks. #threeblindmice US company Nanoscope Therapeutics has developed a new treatment which is hoped will restore vision in those affected by retinal...

Twenty-five years in retina

In the next of our articles celebrating 25 years of Eye News, the authors look at how the retina specialty has changed over this time and ask what the future might hold. Retinal disease management has benefited from great advances...

Retinal Pharmacotherapeutics (Developments in Ophthalmology)

Retinal Pharmacotherapeutics is volume 55 in the ‘Developments in Ophthalmology’ series released by Karger. As the name of the series suggests it aims to explore current and future developments in retinal therapeutics. The book itself is split into six main...

Corporate M&A pace gathers momentum

Intensifying franchise competition, maturing product development pipelines and looming loss of exclusivity spur renewed merger and acquisition (M&A) activity in the ophthalmics sector. Rod McNeil reviews recent deals and related strategic developments. AbbVie to acquire Allergan in $63 billion mega-combination,...

Congratulations to the SOC poster prize winners!

The Scottish Ophthalmological Club (SOC) recently hosted another excellent webinar on the theme ‘Post COVID – The Best of Times and The Worst of Times'.

Visit the Bausch + Lomb virtual exhibition this weekend at ESCRS and Euretina symposia

Bausch + Lomb are proud to be supporting and exhibiting at the virtual ESCRS and Euretina meetings this coming weekend, 2 – 4 October.